Duke University are developing a novel approach that will force the virus out of a latent state and allow it to be killed by existing drugs like acyclovir. This could completely rid a person's body of the herpes virus. It is the most complete treatment currently being researched. To donate to the Duke project, you have to carefully follow the University's instructions:

“Two-thirds down The Duke University donations page there is a text box where you can type designation comments. In this box type: Professor Bryan Cullen account 391-1628. All gifts designated for this account must be credited to this account, or they will end up going to another department of the university.”

You can also donate to Duke University by regular mail:

Alumni and Development Records
Duke University Box 90581
Durham, NC 27708-0581
Phone: (919) 684-2338
Fax: (919) 684-8527

In the memo line of the check, please write: Professor Bryan Cullen 391-1628.

Update

Press Release, download here

The 2008 update, download here.

(Date posted: Aug. 4, 2010)

18th Conference on Retroviruses and Opportunitic Infections (Posted: May 15, 2011)

Click here for Cullen's Lab latest news update.

The University of Florida is researching a novel cure that may cause the herpes virus to become inactive in people who already carry the virus. The researchers, led by Dr David Bloom, are accepting donations.

There are two types of herpes simplex virus, HSV-1 and HSV-2. Because they are nearly identical, research into one virus helps research into the other. You can donate to the University of Florida's HSV-1 research here , and HSV-2 research here . You can read more about the research here .

Update

Dec. 2, 2010 update

Jan. 12, 2011 update

March 7, 2011 update

Virologist William Halford showed that mice vacinated with a live, genitically modified herpes simplex virus type 1 (HSV-1) showed no signs of disease 30 days after being exposed to a particularly lethal "wild-strain" of the virus. In contrast, a second group of mice that recieved a more conventional vaccine died within six days of being exposed to the same "wild-type" strain. read more...

 You can donate here.

Harvard medical school are working on a vaccine. The research is led by Dr David Knipe and his team of scientists at Knipe Lab. To donate to this research, visit the research website here .